chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash primarily on side of left torso underneath where lymph nodes had been removed 2 years ago due to breast cancer; Very itchy; This is a spontaneous report from a non-contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown) via unknown route of administration on an unknown date as DOSE 1, SINGLE and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EP6955) via unknown route of administration in right arm on 04Apr2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history included melanoma in situ and breast cancer. the patient concomitant medication included Tamoxifen for an unknown indication from an unknown date. patient did not have other vaccine in four weeks. It was reported that on 15Mar2021, a very small rash on wrists within 12hours of the first dose of the vaccine. Very itchy. Persisted for two weeks. After, second dose, same type of rash flared one week after the shot. Rash primarily on side of left torso underneath where lymph nodes had been removed 2 years ago due to breast cancer. Very itchy. Persists for 1 week so far. Patient did not receive treatment. Patient did not have COVID prior vaccination and not tested for COVID post vaccination. The outcome of the events were not recovered.  No follow-up attempts were possible. No further information was expected.
allergic reaction. tongue swelling within couple minutes, tightness in chest, lungs tight, burning in chest lasted 10 minutes, subsided after a while. wanted to report what she had, concerned with second and if she should take Benadryl
Patient had rash all over body for several days. Patient did not see a doctor and didn't tell me about it until much later.
Weakness in arm, elbow, and wrist. Now I have no strength in my right arm. When putting pressure against my hand, it shoots a pain up my right arm. Hurts to use a computer mouse with my right wrist. Hurts to turn or twist right arm now. Weakness to grab or pick up things with my right hand. Have not sought medical attention yet. Waiting to see if it wears off. Went to the Chiropractor and nothing is out of place.
COVID vaccine Lot 33025BD, removed from freezer 12-17-21 at 930am, administered to patient on 1-17-2022 after 930am. NO adv rx from pt
Sore injection site; Nausea; Bodyaches; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 17Mar2021 15:45 (Lot number: ER2613) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Route of administration: intramuscular, left arm, Batch/lot number: ENG201, Severe Bodyaches, Headache, Sore injection, Onset date 20Feb2021), administration date: 19Feb2021, when the patient was 43 years old, for Covid-19 Immunisation. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 19Mar2021, outcome "recovered" (2021), described as "Sore injection site"; NAUSEA (non-serious) with onset 19Mar2021, outcome "recovered" (2021), described as "Nausea"; PAIN (non-serious) with onset 19Mar2021, outcome "recovered" (2021), described as "Bodyaches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of injection site pain, nausea, pain.  Additional information: The patient did not taken prior Vaccinations.  No follow-up attempts are possible. No further information is expected.
This case was reported by a consumer and described the occurrence of lethargy in a 61-year-old male subject who was vaccinated with (Flulaval, GlaxoSmithKline) for prophylaxis. The reporter is the subject. A physician or other health care professional has not verified this report. The subject's medical history included deafness in one ear, heart attack and high blood pressure. The subject reported that 10 years ago he had a flu shot and had a cold all that winter. Since then, the subject has had a flu shot yearly and has not had any problems. Concurrent medications included Omeprazole (Prilosec), Aspirin (Baby ASA), Atorvastatin calcium (Lipitor) and Clopidogrel bisulphate (Plavix). On 18 October 2007 at 5:00 p.m. the subject received unspecified dose of Flulaval (.5 ml, unknown). A few hours later, on 18 October 2007, less than one day after vaccination with Flulaval, the subject experienced lethargy, tightness in his throat and a dry cough. At 3:30 a.m. on 19 October 2007, the subject experienced night sweats and chills. On 04 November 2007 the subject experienced dizziness and noise in his ears. On an unspecified date, less than one month after receipt of Flulaval, the subject experienced difficulty with mental focusing. The subject was seen at a physician's office. The subject considered the events to be disabling. At the time of reporting the outcome of the events were was unspecified.
I am unsure if it could be related but a little more than 3 months after my vaccine I had developed sepsis from an infected tooth and coincidentally it was discovered I now have Tietze Syndrome.
A physician reported that a pt received Pnu-Imune 23 and (1999-2000) influenza virus vaccines in 10/99 and subsequently developed a "very" swollen arm and "felt ill, kind of achy all over". This is 1 of 3 pts from this facility to experience this event following receipt of Pnu-Imune 23 lot 466787. The reporter indicated that 3 pts experienced this event; however; they are not presently identifiable. Additional reports will be generated when identifying information is provided.
chills; low grade fever; This spontaneous report was received from a physician, referring to a 57 year old male patient. The patient's concurrent conditions and medical history were not reported. Concomitant therapies included pantoprazole.     On 09-AUG-2021 (also reported as "seven days ago"), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, frequency, route of administration, anatomical location of vaccination, lot number and expiration date were not reported) as prophylaxis.   Since that same day, he had been experiencing periodic low-grade fevers (pyrexia), with body temperature between 99.2 - 99.4 degrees fahrenheit (F), mostly in the evenings. The physician stated the patient's baseline temperature was 97.6 - 97.8 F, so while the fevers were low-grade the patient was very aware of them. The patient had also stated he experienced chills, but the physician did not think they had been rigors. On an unspecified day in August 2021, the patient went to an urgent care where he received negative coronavirus disease 2019 (COVlD-19) and streptococcus (reported as "strep") tests. The patient sought medical attention and only received acetaminphen (TYLENOL) as treatment for the events. The outcome of both events was reported as not recovered by the physician.   The reporting physician did not provide a causality assessment between the vaccine and the events; however, it was reported that when the patient went to the urgent care he was told (by an unreported contact) the symptoms were likely a reaction to pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).
pt recv vax & devel fever, rash, joint pain, lt knee effusion & myalgia; pt recovered;
Information has been received from a medical assistant concerning her coworker an "early 30s" female healthcare worker who on unspecified dates was vaccinated with two series of hepatitis B virus vaccine rHBsAg (Lot#, dose and route not reported). It was reported that the patient continued to test negative for blood titers. The patient was performed physician examination for medical attention. No adverse effect had been reported or observed. The patient was not given any treatment. Follow up information was received from a physician reporting that the female patient on an unknown dates received 2 doses of hepatitis b vaccine (manufacturer unknown) on schedule but did not received the third dose. In 2008 she received three doses on schedule of RECOMBIVAX HB and still had a negative hepatitis B titer. No adverse effects were reported. No treatment was given for the experience. Follow up information was received from a physician reporting that the 31 years old female medical assistant with diabetes mellitus and no illness at time of vaccination who on 25-NOV-2008, 23-DEC-2008 and 10-JUN-2009, was vaccinated on her left deltoid with the three doses of RECOMBIVAX HB (lot numbers 659669/0062X, Exp. Date: 16-AUG-2010, 1355X and 663282/0086Y, Exp. Date: 28-AUG-20119) respectively (doses and route not reported). It was reported that the patient had also two shots of hepatitis B vaccine (manufacturer unknown) in 2005 (she missed one dose) and she had not developed immunity to it. On 21-JUL-2011 a hepatitis B surface antigens were performed and < 0.1 was showed as a result and hepatitis panel was within normal limits. On 12-JUL-2012, a rechecked was performed and still negative. At the time of the report, the patient's outcome was unknown. The relatedness for patient received three doses on scheduled of hepatitis b vaccine and still has a negative hepatitis b titer was unknown for RECOMBIVAX HB. Additional information is not expected.
This is a spontaneous report received from noncontactable consumer or other non-HCP (patient). A 17-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FD0809), at the age of 17, in right arm, on Oct 4, 2021, at 14:45, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. The patient developed pyrexia (fever of 100.6 and climbing), onset Oct 5, 2021, at 13:00, with outcome of not recovered. Relevant laboratory tests and procedures available in the appropriate section. Additional information: Patient did not receive any other vaccine within four weeks of vaccination. Patient did not have COVID-19 prior vaccination and has not tested positive post vaccination. Follow-up attempts completed. No further information expected.
11/26/21: Pt admitted to the hospital. Currently on 4L, wean as tolerated. Started on pulmicort, combivent, decadron, vit d, vit c, zinc. on arrival, his O2 sats were 73% on room air. On 4L of O2, it increased to 88%. begin remdesivir 11/27: chest xray shows worsening bilateral infiltrates. continue bronchodilators and current therapy. intensivist following given intubation/mech vent.  11/28-30: continue therapy and monitor patient. patient has gotten worse considering a concurrent pseudomonas infection before covid admission  12/01: patient deceased
tingling from the toes to arms and head. dizziness started a few minutes later and then  the tingling started again. patient then got nauseous and light headed and passed out. she had to be taken to the hospital by ambulance. patient did not recover for about  3 hours from time of onset of symptoms. mild symptoms continued for 4 days thereafter
Fluaval was given by error to a 6 weeks old male. Patient had colic (as preexisting) Monitored in the office for an hour close follow up for the following 2 days: no adverse effects reported (No fever, no changes in feeding)
had a sore arm(For the first 2 doses); This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (had a sore arm(For the first 2 doses)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 031M20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug hypersensitivity (Gabapentin makes patient nauseated and have vertigo), Asthma (underlying asthma which is usually in control) and Autoimmune disorder NOS. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (had a sore arm(For the first 2 doses)). At the time of the report, PAIN IN EXTREMITY (had a sore arm(For the first 2 doses)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.  For the first 2 doses, patient had no trouble at all, only had a sore arm that went away after a fewdays.
No additional adverse event reported; Patient received a dose of improperly stored ROTATEQ; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 17-JAN-2020, the patient was vaccinated with a dose of improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) of lot # S004399 with expiry date 06-NOV-2020 via oral route (frequency unknown) for prophylaxis (product storage error). On an unknown date, the vaccine was exposed to the temperature below 36 degree Fahrenheit (16 F) for 2 hours and 30 minutes and below 24 Fahrenheit (16.7 F) for 1 hour and 30 minutes, 1 cycle. There was no previous temperature excursion reported. Digital data logger was involved. No adverse effect reported.
No additional AE details.; Medical assistant calling to report expired dose of VARIVAX was administered today.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-JUN-2022, the patient was vaccinated with an expired dose of varicella virus vaccine live (OKA/MERCK) (VARIVAX) (valid lot #T016000, expiration date: 08-MAY-2022) (strength, route of administration and anatomical location were not provided), however, the sterile diluent used to reconstitute the vaccine (valid lot #T017425, expiration date: 22-DEC-2022) (strength, route of administration and anatomical location were not provided) was not expired. None of them had any temperature excursions. No additional adverse events were reported.
Patient stated she developed severe redness, pain, and swelling in the arm. She went to the ER at the advice of her doctor and was diagnosed with cellulitis and placed on antibiotics.
Sunday night after getting home from work I had a severe attack of losing balance, dizziness and nausea/vomiting from the room spinning. I also had the feeling of fullness and feeling like I can?t hear as well out of my right ear for two days now.
Chest discomfort; Pyrexia; Headache; Tested positive for COVID after vaccination; Lack of efficacy; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID after vaccination), DRUG INEFFECTIVE (Lack of efficacy), CHEST DISCOMFORT (Chest discomfort), PYREXIA (Pyrexia) and HEADACHE (Headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Hepatitis C.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Oct-2021, the patient experienced COVID-19 (Tested positive for COVID after vaccination) and DRUG INEFFECTIVE (Lack of efficacy). On an unknown date, the patient experienced CHEST DISCOMFORT (Chest discomfort), PYREXIA (Pyrexia) and HEADACHE (Headache). At the time of the report, COVID-19 (Tested positive for COVID after vaccination), DRUG INEFFECTIVE (Lack of efficacy), CHEST DISCOMFORT (Chest discomfort), PYREXIA (Pyrexia) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Oct-2021, SARS-CoV-2 test positive: positive (Positive) Positive.         No concomitant medication was reported by the reporter. No treatment was reported by the reporter.; Sender's Comments: This case concerns a 58-year-old male patient with medical history of Asthma and Hepatitis C, who experienced the unexpected events of SARS-CoV test positive and chest discomfort, and the expected events of pyrexia and headache. Latency 6 months and 8 days after the first dose of mRNA-1273. Drug ineffective was considered as an additional event. The rechallenge was not applicable, as no additional dosing will be given. The medical history of Asthma could be potentially confounder for the event of chest discomfort. The benefit-risk relationship of vaccine in not affected by this report. The case was assessed as non-serious based on reported seriousness and medical judgement.
Pregnant; Horrible body aches; Headache; This spontaneous prospective pregnancy case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), PAIN (Horrible body aches) and HEADACHE (Headache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety, Migraine and Allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 19-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), PAIN (Horrible body aches) and HEADACHE (Headache). On 19-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, PAIN (Horrible body aches) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported.
Child received immunizations 1/11/08. Went to ER on 1/12/08 - bloody stools - diagnosed with intussusception (surgical reduction required).  01/31/2008 MR received from CDC including vax record confirming vax as reported and hospital records from DOS 1/12-15/2008 with DX: Ileocolic Intussusception. Infant presented to ER with progressive nausea, vomiting and bloody diarrhea.  PO intake decreased. Surgical consult PE (+) for lethargy,  abdominal tenderness and a RUQ density on deep palpation. IS was not reducible by BE so pt had surgical reduction of IS and appendectomy.
Temporary facial numbness and tingling, heart palpitations for weeks now (I only used to get them maybe once a month now it's every day)
I woke the next day at 7am after my second Pfizer covid-19 vaccine feeling fine with just a little soreness at the injection spot. Had my usual breakfast (tea and cereal) and headed to work. Around 11am I started to feel hot but couldn't take my temperature and eventually felt lightheaded and nauseous . I walked to the nearest bathroom to lay down in cool air but didn't make it. Everything went black and I fainted. I was awaken by another worker I'm still not sure how long I was out for, probably a minute or two. The paramedics arrived ten minutes later and performed a few tests and recommended I go to the hospital to check my head, which had a massive bump caused by the fall. I refused and preferred to rest at home. Besides the physical injuries from my fall I recovered quickly with no signs of fever or other symptoms related to a concussion.
Administered vaccine after 33 days in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Loss of voice, shortness of breathe, chest pain, fever, weakness, malaise. Treated with Zithromycin (Z-pack) x 2.
case was tested prior to having leg surgery on 1/20. tested positive but still admitted to hospital for leg surgery on 1/20. still in hospital as of 1/27
4/6/2021   Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  urticaria.   Assessment : Time of assessment 304pm. Alert and oriented and Urticaria.   Actions taken:  Vitals sign taken  VAERS form obtained and completed by RN.   VS at 304pm , BP 123/68, P- 86, O2- 99%   Medications administered:  - Benadryl 25 mg tab PO x 1 at 324pm by RN - Famatodine 1o mg 1 po x 1 at 304pm by RN,  Loratadine 10 mg 1 po x 1 by RN at 304pm by RN.     Disposition: discharged home with no further complaints, husband with patient and is patient driver. Patient instructed to follow up with PCP regarding further covid vaccines, she was provided vaccine information and discharged home.     Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 4/6/2021  2:39 PM 0.3 mL 12/11/2020 Intramuscular
Awakening  on Saturday, March 13, I saw blood on my pillow and a pee spot on the bed (my first time for either).  I could barely get out of bed (an awkward rollover did it).  My tongue was numb (still is) and raw from the presumed chewing on it.  Walking was slow and painful as all muscles hurt.  If I sneezed or coughed, my back would hurt.  Those last problems are still true. I periodically cough up phlegm and lacking a good place to spit it out, I just swallow it.  I have for the first time in my life been using a walker for stability. Right arm is almost useless due to pain.
Pain at injection site, pain in left wrist, fatigue, lightheadedness  Took 500 mg acetaminophen, went to bed on January 21 at 10 pm and got up at 11:30 am on January 22 feeling pretty good. Now on January 23 at 4 pm the only remaining effect is some stiffness in my left hand.
Woman is 71 yrs. old and is experiencing spotting. No med changes except administration of Moderna.
Had shot on 27AUG90; Had fever 105 that night; Seen in Hosp ER; MD states thinks it was ear infect, not DTP;
CAME BACK APPROX. 4 HOURS LATER C/O PAIN IN BACK.
COVID-19 + on 2/7/22. 2/5/22 symptoms started with body aches, headache, cough, and fatigue.
PPV 23 and flu vaccine given 10:00 AM on 11/18/08. On set of fever (101 ear canal), pain, induration, erythema measuring 16 cm top to bottom and 13 cm side to side. PPV 23 injection site 3 cm distal to top margin, flu site 1 1/2 cm distal to top margin.